SCHEMBL8779911

SCHEMBL8779911

COc1ccc(-c2ncc3ccccc3n2)nc1Oc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.56
LMNA P02545 4/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
ALDH1A1 P00352 6/20 0.49
TDP1 Q9NUW8 1/20 0.49
KMT2A Q03164 7/20 0.46
MEN1 O00255 5/20 0.46
POLB P06746 2/20 0.46
MAPT P10636 4/20 0.44
NPSR1 Q6W5P4 2/20 0.44
CYP1A2 P05177 2/20 0.44
CYP2C9 P11712 2/20 0.44
CYP2C19 P33261 2/20 0.44
PPP1CA P62136 2/20 0.44
GAA P10253 1/20 0.43
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
CYP3A4 P08684 1/20 0.40
ABCG2 Q9UNQ0 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3792084 0.84 L3MBTL1 (0.43) L3MBTL1LMNASMN1; SMN2ALDH1A1TDP1
SCHEMBL8779764 0.81 SMN1; SMN2 (0.43) L3MBTL1LMNASMN1; SMN2ALDH1A1TDP1
SCHEMBL8777721 0.81 ALDH1A1 (0.48) L3MBTL1LMNASMN1; SMN2ALDH1A1TDP1
SCHEMBL8777598 0.80 ALDH1A1 (0.43) L3MBTL1LMNASMN1; SMN2ALDH1A1TDP1
SCHEMBL8779812 0.79 L3MBTL1 (0.46) L3MBTL1LMNASMN1; SMN2ALDH1A1TDP1
SCHEMBL8777669 0.78 MAPT (0.46) L3MBTL1LMNASMN1; SMN2ALDH1A1TDP1
SCHEMBL8777646 0.77 L3MBTL1 (0.48) L3MBTL1LMNASMN1; SMN2ALDH1A1TDP1
SCHEMBL3787309 0.76 ALDH1A1 (0.51) L3MBTL1LMNASMN1; SMN2ALDH1A1TDP1
SCHEMBL8779883 0.76 SMN1; SMN2 (0.39) L3MBTL1LMNASMN1; SMN2ALDH1A1KMT2A
SCHEMBL8777583 0.76 L3MBTL1 (0.47) L3MBTL1SMN1; SMN2ALDH1A1KDM4ENPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012069652-A2 FUNGICIDE MIXTURES SYNGENTA PARTICIPATIONS AG (CH) 2012-05-31 WO disclosed
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA CROP PROTECTION, LLC (US) 2012-05-24 US disclosed
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA CROP PROTECTION, LLC (US) 2012-05-24 US disclosed
WO-2010136475-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES SYNGENTA PARTICIPATIONS AG (CH) 2010-12-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120129875-A1 SUBSTITUTED QUINAZOLINES AS FUNGICIDES NAT1, NQO2, NOX1 L3MBTL1 3069/4885LMNA 3612/4885SMN1; SMN2 3646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.